Search tips
Search criteria 


Logo of jcellbiolHomeThis articleEditorsContactInstructions for Authors
J Cell Biol. 2010 March 8; 188(5): 639–652.
PMCID: PMC2835929

ATR suppresses telomere fragility and recombination but is dispensable for elongation of short telomeres by telomerase


Telomere shortening caused by incomplete DNA replication is balanced by telomerase-mediated telomere extension, with evidence indicating that the shortest telomeres are preferred substrates in primary cells. Critically short telomeres are detected by the cellular DNA damage response (DDR) system. In budding yeast, the important DDR kinase Tel1 (homologue of ATM [ataxia telangiectasia mutated]) is vital for telomerase recruitment to short telomeres, but mammalian ATM is dispensable for this function. We asked whether closely related ATR (ATM and Rad3 related) kinase, which is important for preventing replicative stress and chromosomal breakage at common fragile sites, might instead fulfill this role. The newly created ATR-deficient Seckel mouse strain was used to examine the function of ATR in telomerase recruitment and telomere function. Telomeres were recently found to resemble fragile sites, and we show in this study that ATR has an important role in the suppression of telomere fragility and recombination. We also find that wild-type ATR levels are important to protect short telomeres from chromosomal fusions but do not appear essential for telomerase recruitment to short telomeres in primary mouse embryonic fibroblasts from the ATR-deficient Seckel mouse model. These results reveal a previously unnoticed role for mammalian ATR in telomere protection and stability.


Telomeres are nucleoprotein structures that protect the ends of eukaryotic chromosomes from DNA repair and degradation activities. Telomeres comprise complexes of tandem DNA repeats (TTAGGG in vertebrates) bound by a specialized multiprotein complex known as shelterin (Palm and de Lange, 2008). Shelterin contributes to the protective function of telomeres by cancelling DNA damage response (DDR) activation at telomeres and preventing potential telomere fragility (Martínez et al., 2009b; Sfeir et al., 2009). In particular, recent studies demonstrate that the shelterin protein TRF1 is essential to prevent telomere breakage associated with replication fork stalling at telomeres (Martínez et al., 2009b; Sfeir et al., 2009). TRF1 deletion leads to uncapping and fusion of telomeres and to increased numbers of telomeres with multiple telomeric signals (MTSs), an aberrant structure that is enhanced by conditions known to cause replication fork stalling, such as aphidicolin treatments (Martínez et al., 2009b; Sfeir et al., 2009). Chromosomal defects associated with TRF1 deficiency are also accompanied by the activation of an ATM (ataxia telangiectasia mutated)/ATR (ATM and Rad3 related)-dependent DDR (Martínez et al., 2009b; Sfeir et al., 2009). Interestingly, the important DDR kinase ATR functions protecting and stabilizing stalled replication forks during DNA synthesis and is essential for preventing chromosomal gaps and breaks at common genomic fragile sites (Casper et al., 2002, 2004; Murga et al., 2009). The recent description of telomeres resembling fragile sites (Sfeir et al., 2009) suggests that ATR may have an important function in the maintenance of telomere stability. A role for ATR at mammalian telomeres is further supported by evidence showing that ATR can be found at mammalian telomeres during late replication (Verdun and Karlseder, 2006) as well as by the known role of Drosophila melanogaster ATR in telomere function (Bi et al., 2005).

Telomere length can be modulated by telomerase, a telomere-specific reverse transcriptase that uses its intrinsic RNA subunit as a template to add telomere repeats to chromosome ends (Chan and Blackburn, 2002). Telomerase is expressed in stem cell compartments and cancer cells, but adult tissues do not express sufficient telomerase for continuous telomere maintenance (Blasco, 2005). Because of incomplete replication of linear DNA ends, telomeres shorten with progressive rounds of cell division until critically short, leading to increased genomic instability and eventually to cell cycle arrest and apoptosis, which in turn contribute to organismal ageing (Blasco, 2005). Under conditions of telomere shortening, the shortest telomeres are thought to be the preferred substrate for telomere lengthening by telomerase in yeast, primary mouse cells, and some human cell lines (Hemann et al., 2001; Perrem et al., 2001; Samper et al., 2001a; Liu et al., 2002; Teixeira et al., 2004; Zhao et al., 2009), although this is not the case for some human cancer cell lines (Zhao et al., 2009). However, the mechanism enabling telomerase to recognize short telomeres is not clearly defined. A paradigm exists in budding yeast Saccharomyces cerevisiae in which the Tel1 checkpoint kinase (homologue of mammalian ATM) is a critical telomere length regulator; Tel1 deletion results in dramatic telomere shortening, telomere fusion, and elevated telomere recombination (Greenwell et al., 1995; DuBois et al., 2002). Telomere length in tel1Δ cells eventually stabilizes at a minimum length of 50 bp (about sevenfold shorter than wild-type telomeres; Lustig and Petes, 1986), with residual telomere length being maintained by the activity of the closely related Mec1 kinase (homologue of mammalian ATR). Deletion of Mec1 on its own has little effect on telomere length, but mec1Δ tel1Δ double mutants exhibit progressive telomere attrition and eventual complete loss of telomeres (Ritchie et al., 1999), a phenotype similar to cells lacking telomerase components (Singer and Gottschling, 1994; Lendvay et al., 1996). Telomerase activity is normal in these cells, and the short telomere phenotype of the tel1Δ and mec1Δ tel1Δ strains can be overcome by fusing telomerase to the telomere end–binding protein Cdc13 (Chan et al., 2001; Tsukamoto et al., 2001), suggesting that these cells are defective in the recruitment of functional telomerase to short telomeres (Pennock et al., 2001; Bianchi et al., 2004; Tseng et al., 2006). Furthermore, budding yeast Mec1 has been proposed to have roles facilitating fork progression at specific regions in the genome (Cha and Kleckner, 2002), which are characterized by slow replication, as well as in regulating dNTP (deoxyribonucleotide triphosphate) pools (Zhao et al., 1998), suggesting essential roles for Mec1 in replication. Although Tel1 is the major regulator of telomerase recruitment in budding yeast, an opposite scenario exists in fission yeast Schizosaccharomyces pombe, in which deletion of the ATR homologue Rad3 causes severe telomere shortening, but tel1Δ cells have normal telomeres (Dahlen et al., 1998; Nakamura et al., 2002). Simultaneous deletion of rad3Δ tel1Δ is synergistic and causes the complete loss of telomere signal, defective telomerase recruitment, elevated telomere recombination, and reduced binding of the shelterin components Tpz1 and Ccq1 (Nakamura et al., 2002; Moser et al., 2009). Thus, in yeast cells, the phosphoinositide-3-kinase–related kinase (PIKK) family members ATM and ATR make important contributions to telomerase recruitment and telomere length maintenance.

Given their resemblance to DNA double-strand breaks, it is not surprising that short dysfunctional telomeres activate DDRs mediated by the ATM and ATR checkpoint kinases (Guo et al., 2007; Longhese, 2008). In the presence of DNA damage, ATM and ATR phosphorylate a variety of downstream target proteins, variously affecting checkpoint-mediated cell cycle arrest, DNA repair, apoptosis, and senescence (Matsuoka et al., 2007). A short telomere–induced DDR is manifested through the accumulation at critically short telomeres of phosphorylated ATM, 53BP1, γ-H2AX, the MRN (Mre11–Rad50–Nbs1) complex, and Rif, forming so-called telomere dysfunction–induced foci (d'Adda di Fagagna et al., 2003; Takai et al., 2003; Verdun and Karlseder, 2006; Longhese, 2008). Paradoxically, several important DDR proteins also localize to telomeres in the absence of DNA damage, some of which have a role in telomere protection from DDRs, telomere length maintenance, and telomere replication, including ATM, ATR, MRN, Ku86, ERCC1, PARP2, BLM (Bloom syndrome protein), and WRN (Werner syndrome protein; Blasco 2005; Verdun and Karlseder 2006), demonstrating that there is critical interplay between DDR proteins and telomere metabolism in eukaryotic cells.

Because it was first observed that ATM-deficient human cells have shorter telomeres than normal cells (Metcalfe et al., 1996; Pandita, 2002) and this was later confirmed in ATM-null mice (Hande et al., 2001), a role for ATM in telomere length regulation in mammals has been sought. However, simultaneous deletion of ATM and Terc in mice does not lead to accelerated telomere shortening with respect to the single Terc−/− controls, although it causes increased genomic instability and increased apoptosis relative to mice lacking either gene alone, implying that ATM depletion increases dysfunction of short telomeres but is not required for inducing cell death or for telomere maintenance (Qi et al., 2003; Wong et al., 2003). In line with this, ATM was demonstrated to be dispensable for telomerase-mediated elongation of short telomeres in mammalian cells (Feldser et al., 2006). These findings prompted us to ask whether ATR might be a critical regulator of telomerase recruitment, as well as of the recently described resemblance between telomeres and common fragile sites (Sfeir et al., 2009).


Generation of mice and cells doubly deficient in ATR and Terc

In contrast to ATM, analyzing the role of ATR in mammals has been hampered by the essential nature of the kinase (Brown and Baltimore, 2000; de Klein et al., 2000). Thus, the effects of ATR depletion in adult mice and cells have been tested only in the context of in vitro cell culture models or conditional ATR deletion in already adult animals (Ruzankina et al., 2007). To address the role of ATR in the regulation of telomerase recruitment, we used the Seckel syndrome mouse model recently generated by us (Murga et al., 2009). In a subset of human patients with Seckel syndrome, a single point mutation in ATR exon (E) 9 leads to aberrant splicing and severely decreased ATR protein expression and is the cause of growth retardation, microcephaly, brain and skeletal abnormalities, and highly unstable cellular genomes (O'Driscoll et al., 2003; Casper et al., 2004). The Seckel mouse model used in this study harbors a humanized ATR allele in which the region encompassing murine E8, E9, and E10 has been swapped by the human counterpart containing the Seckel mutation in E9 (Murga et al., 2009). This leads to a splicing defect in the E8–E10 boundary, which severely reduces ATR levels and recapitulates the human Seckel syndrome phenotypes in mice (Murga et al., 2009).

Mice lacking the RNA component of telomerase, Terc, show progressive telomere shortening from the first generation until the third or fourth generation (when in a pure C57BL6 background), by which stage they present critically short telomeres, defective stem cell proliferative capacity, infertility as the result of germ cell apoptosis, and increased genomic instability (Blasco et al., 1997; Herrera et al., 1999; Flores et al., 2005). We and others have shown that the restoration of telomerase activity in these mice, by reintroduction of one copy of the Terc gene, rescues critically short telomeres and reverses chromosomal instability and cell and tissue defects associated with late-generation telomerase deficiency (Hemann et al., 2001; Samper et al., 2001a; Siegl-Cachedenier et al., 2007).

To directly test whether ATR proficiency is necessary for telomerase action specifically on short telomeres in primary mouse embryonic fibroblasts (MEFs), we crossed ATR+/S/Terc+/− females with G2 ATR+/S/Terc−/− males to generate littermate populations of ATRS/S and ATR+/+ mice that were also either G3 Terc−/− or G3 Terc+/−. The G3 progeny of these crosses inherited a set of chromosomes with short telomeres from the male G2 ATR+/S/Terc−/− parent and a set of chromosomes with normal telomeres from the female ATR+/S/Terc+/− parent (and are hereafter referred to as G3 Terc−/−* or G3 Terc+/−*; Fig. 1 A), but only the G3 Terc+/−* progeny would inherit a copy of the Terc gene and be telomerase proficient (Fig. 1 B). To confirm ATR abrogation in MEFs derived from the ATRS/S progeny, we first demonstrated that ATR expression is undetectable in ATRS/S compared with ATR+/+ MEFs, as determined by Western blotting experiments (Fig. 1 C). As expected, Terc deficiency did not affect ATR expression levels (Fig. 1 C, compare the first and second lanes with the third and fourth lanes). We also confirmed that reintroduction of the Terc allele successfully reconstituted telomerase activity in both ATR+/+/G3 Terc+/−* and ATRS/S/G3 Terc+/−* MEFs (Fig. 1 B), demonstrating that telomerase processivity and activity is not affected by ATR depletion, which is similar to what has been previously reported for cells lacking ATM (Sprung et al., 1997).

Figure 1.
Generation and characterization of Seckel Terc compound mice. (A) Outline of the ATR+/S/Terc+/− × ATR+/S/G2 Terc−/− cross. G3 progeny inherit one set of short telomeres (from the G2 Terc−/− parent) and one ...

Severely decreased ATR levels in primary Seckel MEFs do not significantly impair elongation of short telomeres by telomerase

Next, we sought to directly test whether short telomeres inherited from the G2 Terc−/− father are elongated properly in telomerase-reconstituted ATRS/S cells. For this, we determined the telomere length of the Y chromosome using quantitative FISH (Q-FISH; Poon et al., 1999) in male littermate MEFs of each genotype under study: ATR+/+/G3 Terc+/−*, ATR+/+/G3 Terc−/−*, ATRS/S/G3 Terc+/−*, and ATRS/S/G3 Terc−/−*. Fig. 2 A shows the telomere length distribution frequency for Y chromosomes from littermate MEFs. As expected, cells receiving the Terc-null allele had a large peak of chromosome ends with undetectable telomeres (bottom panel, signal-free ends [SFEs]), which were completely rescued in cells inheriting the wild-type Terc allele (P < 0.0001; compare i with iii), which is in agreement with telomerase preferentially elongating critically short telomeres in MEFs (Samper et al., 2001a). Importantly, when a similar comparison is made for the ATR-deficient ATRS/S littermates (Fig. 2 A, compare ii with iv and see SFE in bottom panel), we found that telomerase-reconstituted ATRS/S/G3 Terc+/−* were also able to properly elongate critically short telomeres in a similar manner to their ATR+/+ MEF siblings (P = 0.17 for frequency of SFEs; Fig. 2 A, compare i with ii), indicating that wild-type ATR proficiency is dispensable for the rescue of critically short Y chromosome telomeres and that Seckel cells are not compromised in telomerase recruitment to chromosome ends. Fig. 2 A (bottom left) also shows the mean Y chromosome telomere lengths for each genotype. As expected, ATR+/+/G3 Terc+/−* cells show longer mean telomeres (17.87 kb) than their ATR+/+/G3 Terc−/−* littermates (13.45 kb), but this lengthening is observed most dramatically for Yp telomeres, which were 7.14 kb longer; Yq telomeres were only moderately shorter in Terc-null cells (1.69 kb shorter). A similar trend is observed when comparing ATRS/S/G3 Terc+/−* and ATRS/S/G3 Terc−/−* cells, in which very short Yp telomeres were lengthened to a greater extent than Yq telomeres (2.74 kb longer and 0.42 kb longer, respectively). This pattern likely reflects preferential telomerase activity at short telomeres in mouse primary cells, where it appears that only those telomeres that fall below a critical threshold are lengthened and not all telomeres in the cell (Hemann et al., 2001; Samper et al., 2001a).

Figure 2.
ATR proficiency is dispensable for elongation of short telomeres. (A) Telomere length histograms for each genotype (top, i–iv); mean lengths of p arm, q arm, and total telomeres (bottom left); and proportion of SFEs (bottom right) from Y chromosome ...

To further confirm our observation of rescue of short telomeres in ATR-deficient mouse cells, we extended this analysis to additional chromosomes. We used spectral karyotyping (SKY) analysis in combination with Q-FISH (Fig. 2 B) to identify and measure the telomere lengths of specific chromosomes. Fig. 2 C shows that, as we observed for telomeres from the Y chromosome (Fig. 2 A), a population of critically short telomeres identified in Terc-null MEFs on chromosome 1 was effectively rescued by telomerase reconstitution in ATR-deficient ATRS/S/G3 Terc+/−* MEFs to a similar same extent as in ATR+/+/G3 Terc+/−* MEFs (P = 1.00 for SFE; comparison of i with iii and of ii with iv shows rescue of critically short telomeres), again indicating that murine ATR-deficient cells are not compromised in their ability to rescue short telomeres. This pattern is also reflected in the mean telomere lengths observed for chromosome 1 for the different genotypes in Fig. 2 C (bottom left). Although the overall mean telomere length did not change in each of the genotypes, the shorter chromosome 1p telomeres observed in Terc-null mice were increased to an equal length in both ATR+/+/G3 Terc+/−* and ATRS/S/G3 Terc+/−* cells (by 10.72 kb and 10.79 kb, respectively).

Using combined Q-FISH and SKY, we also examined the specific lengths of telomeres from chromosomes 2 and 11 in the different littermate MEFs. Chromosome 2 was examined because it has been found to have a shorter mean telomere length than other mouse chromosomes in several independent mouse strains (Zijlmans et al., 1997; Hande et al., 1999; Samper et al., 2001a), whereas chromosome 11 was chosen because it is homologous to human chromosome 17, which was also reported to have relatively short telomeres (Martens et al., 1998). In the telomere length histograms depicted in Fig. 2 (D [chromosome 2] and E [chromosome 11]), we see that telomerase deficiency in the ATR+/+/G3 Terc−/−* MEFs causes the accumulation of a population of critically short telomeres that were rescued in their ATR+/+/G3 Terc+/−* littermates. In the ATRS/S/G3 Terc−/−* MEFs, this critically short telomere population was less apparent than it was for ATR+/+/G3 Terc−/−*; however, the proportion of telomeres <4 kb was reduced by a statistically significant amount in ATRS/S/G3 Terc+/−* MEFs (P = 0.014 for chromosome 2; P = 0.025 for chromosome 11), indicating that telomerase is able to rescue short telomeres in MEFs devoid of detectable ATR, as previously demonstrated for telomeres on chromosome 1 and the Y chromosome (Fig. 2, A and C). In most cases, the absence of Terc in the ATR+/+/G3 Terc−/−* ATRS/S/G3 Terc−/−* caused increased frequency of SFEs in comparison with their Terc+/−* counterparts, except for the telomeres of chromosome 2 in the ATRS/S MEFs. The reason for this anomaly is not clear but may be related to the presence of shorter telomeres in this chromosome and consequent telomerase-independent lengthening by recombination in the ATRS/S/G3 Terc−/−* population or ATRS/S/G2 Terc−/−* parent, leading to fewer SFEs because Terc−/− cells with short telomeres undergo more frequent telomere recombination than wild-type cells (Benetti et al., 2007b). Curiously, we noticed that the mean length of chromosome 11q telomeres was ~50% shorter than that of 11p telomeres in this MEF population, which is in contrast to the usual trend for p-arm telomeres to be shorter than q-arm telomeres (Fig. 2 E, bottom left; Zijlmans et al., 1997).

Further to our analysis of individual chromosomes, we also examined the telomere length distributions for all chromosomes for each genotype, incorporating three independent MEFs for each. As shown in Fig. 3 A, comparison of ATR+/+/G3 Terc+/−* with ATR+/+/G3 Terc−/−* and of ATRS/S/G3 Terc+/−* with ATRS/S/G3 Terc−/−* shows significantly (P < 0.0001) longer telomeres in the respective G3 Terc+/−* populations, demonstrating telomere elongation upon telomerase restoration in both ATR+/+ and ATRS/S lines. Note especially the dramatic reduction in critically short undetectable telomeres in these cell populations, as shown by arrows in Fig. 3 A. We found that the median telomere length in telomerase-competent ATR+/+/G3 Terc+/−* and ATRS/S/G3 Terc+/−* cells was not significantly different (P = 0.2173) but, surprisingly, the median telomere length of ATR-deficient ATRS/S/G3 Terc−/−* MEFs was significantly longer than ATR+/+/G3 Terc−/−* MEFs, even though the frequency of critically short telomeres was similar in both populations (P < 0.0001).

Figure 3.
Analysis of overall telomere length and telomeric recombination. (A) Histogram of telomere lengths from all chromosomes in G3 ATR+/+ and ATRS/S MEFs. Arrows indicate critically short telomeres in G3 Terc−/−* MEFs that are rescued in G3 ...

Severely decreased ATR levels augment telomere recombination in Seckel MEFs

The overall longer telomeres in ATR-deficient ATRS/S/G3 Terc−/−* MEFs are suggestive of either telomere lengthening caused by increased usage of recombination-based telomere lengthening mechanisms such as ALT (alternative lengthening of telomeres) in ATR-deficient MEFs in the absence of telomerase (Bailey et al., 2004; Gonzalo et al., 2006) or of reduced telomere shortening caused by compromised cell division of ATR-deficient cells (Brown and Baltimore, 2003; Murga et al., 2009). To explore the first possibility, that ATR might suppress telomeric recombination in Terc-deficient cells, we used chromosome orientation FISH (CO-FISH; Fig. 3 B) to directly visualize telomeric sister chromatid exchange (SCE [T-SCE]). A positive T-SCE was scored when chromatid exchange was observed between both leading and lagging strand telomeres (Fig. 3, B and C). Similar to previous observations, we found that ATR+/+ cells lacking telomerase showed increased T-SCE (Fig. 3 D), likely reflecting increased recombination stimulated by short telomeres (Benetti et al., 2007a; Morrish and Greider, 2009). Interestingly, we also observed a significant increase in T-SCE in ATRS/S/G3 Terc+/−* cells in comparison with ATR+/+/G3 Terc+/−* cells, suggesting that ATR may negatively regulate telomeric recombination (Fig. 3 D). In ATRS/S/G3 Terc−/−* cells, T-SCEs were not significantly different to ATRS/S/G3 Terc+/−* or ATR+/+/G3 Terc−/−* cells, implying that the combined deficiency of ATR and Terc does not further increase telomeric recombination (Fig. 3 D). Importantly, global recombination frequencies (SCE) along whole chromosomes were not significantly influenced by either Terc or ATR deficiencies, suggesting a preferential impact of these deficiencies on telomeric repeats (Fig. 4, A and B). Collectively, these data indicate that ATR may negatively regulate telomeric recombination independently of the presence of functional telomerase. These results further indicate that increased telomeric recombination typically associated with ALT is unlikely to contribute to the significant increase in telomere length in ATRS/S/G3 Terc−/−* cells over their ATR+/+/G3 Terc−/−* counterparts, as both cells have similarly elevated telomere recombination frequencies. Although similarities in T-SCE frequencies alone are not sufficient to exclude the use of ALT, the increase in telomere length is more likely the result of delayed cell cycle kinetics in utero caused by limiting amounts of ATR (Murga et al., 2009) or may be the result of the existence of alternative recombination-independent, telomerase-independent mechanisms of telomere elongation.

Figure 4.
Determination of global recombination frequencies (SCE). (A) Quantification of global SCE frequencies. The number of SCE events scored out of the total number of chromosomes is indicated. Data represent at least two independent MEF cultures (n) per genotype. ...

Severely reduced ATR levels do not augment end-to-end fusions caused by short telomeres

Because of its essential role in DNA replication, ATR-deficient cells exhibit massive genome instability, particularly at fragile sites, that are sensitive to the formation of breaks and gaps after replication stress and are hotspots for SCEs, translocations, and deletions (Glover and Stein, 1987, 1988; Casper et al., 2004; Murga et al., 2009). Short dysfunctional telomeres also provoke genome instability, most often in the form of chromosome end-to-end fusions. In mouse primary cells, these fusions mostly involve p:p Robertsonian-like fusions (RLFs) and, to a lesser extent, q:q dicentrics and p:q fusions (Blasco et al., 1997; Herrera et al., 1999). Therefore, we were interested in determining the effects of combined ATR and Terc depletion on chromosomal instability. Short telomeres caused significantly increased end-to-end chromosome fusions in ATR+/+/G3 Terc−/−* cells compared with ATR+/+/G3 Terc+/−* (P = 0.02), a majority of which were RLFs (Fig. 5 A, black bars). Interestingly, ATR depletion in ATRS/S/G3 Terc+/−* cells did not increase RLFs over ATR+/+/G3 Terc+/−*, but other types of fusions were significantly increased (rings, complex aberrations, dicentrics, p:q arm fusions, etc.), likely reflecting stochastic joining of broken chromosomes and chromatids resulting from genome-wide instability in ATRS/S cells (Murga et al., 2009). The fact that the frequency of RLFs is similarly low in ATR+/+/G3 Terc+/−* and ATRS/S/G3 Terc+/−* (Fig. 5 A) indicates that severe ATR dysfunction does not, per se, lead to loss of telomere capping. Instead, the higher variety of chromosomal fusions in ATRS/S/G3 Terc−/−* double deficient cells in comparison with either of the single mutations (P = 0.004 in both cases) suggests that ATR depletion augments the dysfunctionality of short telomeres, as has been previously reported for ATM (Qi et al., 2003; Wong et al., 2003), and likely reflects opportunistic fusion of uncapped or fragile telomeres to chromosome breaks and fragments rather than a direct role for ATR in telomere capping, as suggested by the absence of any telomere length anomalies (Fig. 2) and by similar frequencies of RLFs in ATR+/+ and ATRS/S cells (Fig. 5 A). Finally, as previously reported by us, there was significant elevation in the number of chromatid breaks and fragments in the ATRS/S cells compared with their ATR+/+ littermates (Fig. 5 B; Murga et al., 2009), but these were not affected by the Terc status of the cells because these aberrations do not typically result from critical telomere shortening.

Figure 5.
Chromosomal aberrations in ATR/Terc MEFs. (A–C) Quantification of chromosome fusions (A), chromatid breaks and fragments (B), and MTSs (C) in G3 ATR+/+ and ATRS/S MEFs before (nontreated) or after treatment with aphidicolin. n, number of metaphases ...

ATR prevents telomeres from becoming fragile sites

Consistent with very recent findings, we observed a significant ATR-dependent increase in chromosome ends possessing MTSs, which is also increased in ATR+/+ cells upon aphidicolin treatment (Fig. 5 C; Martínez et al., 2009b). Previously, we have demonstrated that MTSs are increased under conditions of replication stress, such as in ATR-deficient Seckel MEFs as well as in wild-type cells after treatment with the DNA polymerase α inhibitor aphidicolin, and thus, telomeres exhibit hallmark characteristics of common genomic fragile sites (Martínez et al., 2009b). MTSs are also increased in cells lacking TRF1, which is required for efficient telomere replication, and therefore are a direct indicator of telomere fragility resulting from replication fork stalling (Martínez et al., 2009b; Sfeir et al., 2009). In this study, we further demonstrate that ATR-dependent MTSs occur independently of the Terc status of the cell, indicating that telomere fragility is unrelated to telomere length (Fig. 5 C), thus suggesting that short telomeres are not more prone to replication fork stalling. Importantly, we further extended these findings to cells derived from human Seckel patients (O'Driscoll et al., 2003), which also present significantly increased MTSs, as well as increased breaks and fragments, which are further aggravated upon aphidicolin treatment (Fig. S1 A). Of note, we also observed slightly shorter telomeres in human Seckel cells compared with ATR wild-type controls (Fig. S1 B), although this modest telomere shortening was not accompanied by detectable end-to-end chromosome fusions (Fig. S1 A) and therefore is unlikely to cause telomere uncapping.

Notably, in Terc+/−* cells with long telomeres, the ATR-dependent increase in MTSs was also paralleled by an ATR-dependent increase in T-SCE (Fig. 3 D). In addition to breaks and gaps, increased chromosomal instability means that fragile sites are also hotspots for increased recombination by SCE; 70% of all gaps and breaks at a common fragile site also have SCEs at the same site (Glover and Stein, 1987; Durkin and Glover, 2007). Therefore, we suggest that increased telomere recombination observed in ATRS/S MEFs is a direct consequence of increased telomere fragility and that our results indicate that we have revealed an important role for ATR in suppressing two outcomes of fragile telomeres: MTSs and recombination. Interestingly, we also observed a marked elevation in aneuploidy (primarily tetraploidy) in ATRS/S cells in comparison with ATR+/+ (Fig. 5 D), which was not caused by the presence of short telomeres and may instead reflect defective G2/M checkpoint activation in ATR-deficient cells leading to an accumulation of cells with a 4N DNA content (Lin and Dutta, 2007), but the exact molecular mechanism of this remains to be confirmed.

Severe developmental defects in Seckel mice simultaneously abrogated for Terc

The ATR mutation linked to Seckel syndrome causes an array of characteristic phenotypes in both human patients and Seckel mice, including intrauterine and postnatal growth retardation, microcephaly, mental retardation, progeria, and facial and osteoskeletal abnormalities (O'Driscoll et al., 2003; Murga et al., 2009). Because Terc deficiency has been shown to suppress the severity of phenotypes associated with ATM deletion (median lifespan and tumorigenesis; Qi et al., 2003; Wong et al., 2003), we were similarly interested in determining the interaction between ATR and Terc at the whole organism level.

To study the effect of Terc deficiency on Seckel mouse phenotypes, we first examined the impact on reduced lifespan. Critical telomere shortening leads to premature ageing and shortened lifespan in G3 Terc−/− mice, which we confirmed with the observation of significantly reduced survival of ATR+/+/G3 Terc−/− mice compared with ATR+/+/G3 Terc+/− mice (Fig. 6 A). Interestingly, we observed a tendency toward a reduced longevity in ATRS/S/G3 Terc−/− mice compared with ATRS/S/G3 Terc+/− (Fig. 6 A, P = 0.081; almost significant), most likely reflecting the increase in genome instability owed to combined deficiencies of ATR and Terc (Blasco et al., 1997; Murga et al., 2009). However, Terc deficiency did not contribute to the severe dwarfism of Seckel mice, which is already noticeable at birth, here indicated from the measurement of mean body weight at 7 wk of age (Fig. 6 B). Because of severe intrauterine growth defects and developmental abnormalities, Seckel mutant mice were born at reduced non-Mendelian frequencies in comparison with their wild-type and heterozygote littermates, and this was not further aggravated by simultaneous Terc deficiency (Table I; Murga et al., 2009). In line with this, G3 Terc−/−* mice were born at the same frequency as G3 Terc+/−* for all of the ATR genotypes under study (Table I).

Table I.
Telomerase deficiency does not further reduce the low birth rates of ATRS/S mice
Figure 6.
Telomerase deficiency aggravates lifespan attenuation in Seckel mutant mice. (A) Kaplan-Meier survival curve of mice of the indicated genotype. n, number of mice per genotype. Statistical comparisons using log-rank test are shown. (B) Reduced body weight ...

Some of the most prominent phenotypes attributable to the ATRS/S mutation are severe microcephaly and osteoskeletal and cranial defects. Because telomere dysfunction has previously been associated with osteoporosis (Hofer et al., 2005; Pignolo et al., 2008), we were interested in analyzing the severity of osteoporosis and cranial abnormalities in G3 Terc+/−* and G3 Terc−/−* mice by computed tomography (CT) of 10-wk-old mice. However, the already severe osteoporosis associated with the ATRS/S mutation was not worsened in ATRS/S/G3 Terc−/−* mice compared with their ATRS/S/G3 Terc+/−* siblings (Fig. 6 C). Even though telomere defects have previously been linked to osteoporosis in mice, the severity of this is not apparent until old age (14 mo old) in comparison with the early appearance of osteoporosis in much younger (2 mo old) Seckel mice (Murga et al., 2009). Similarly, the severe microcephaly of Seckel mice was not worsened by Terc deficiency, and there were no measurable differences in the dimensions of the cranial cavity, the extent of kyphosis, the length and angle of the nasal bone, mandibular lengths, or the cross-sectional dimensions of the thorax (Fig. S2, A–H) between ATRS/S/G3 Terc+/−* and ATRS/S/G3 Terc−/−* mice. Owing to the fact that Seckel mice have a greatly reduced lifespan, these mice never develop tumors (Murga et al., 2009), which prevented addressing the impact of combined Terc and ATR deficiencies in carcinogenesis. Collectively, these results suggest that combined telomerase and ATR deficiencies seem to have a negative impact of longevity but do not worsen characteristic phenotypes of ATRS/S mice, most likely because of the early onset of Seckel phenotypes.


Given that the yeast Tel1 and Mec1/Rad3 checkpoint kinases are critical for telomere length maintenance, a similar role was expected for their mammalian counterparts, and because murine ATM was proven dispensable for the lengthening of short telomeres, ATR was suspected to fulfill this role (Feldser et al., 2006; Sabourin and Zakian, 2008). We demonstrate in this study for the first time that a severe reduction in ATR levels does not impair telomerase-mediated elongation of short telomeres in mouse primary fibroblasts but has an important role in the prevention of telomere fragility and recombination.

ATR primarily functions to prevent replicative stress and genomic instability. In particular, ATR depletion leads to increased chromosome breakage, especially at fragile sites, both in human and mouse ATR-deficient Seckel cells (Casper et al., 2004; Murga et al., 2009). Consistent with this, we observed an ATR-dependent, Terc-independent increase in MTSs at chromosome ends, an aberration diagnostic of telomere fragility resulting from stalled DNA replication (Martínez et al., 2009b; Sfeir et al., 2009), and we further confirmed these results in cells derived from human Seckel patients. Furthermore, we also observed increased T-SCE in both ATRS/S/G3 Terc+/−* and ATRS/S/G3 Terc−/−* MEFs, indicating a role for ATR in the negative regulation of recombination at telomeres. Common fragile sites are genomic regions prone to replication fork stalling that exhibit increased formation of chromosome gaps and breaks and are also hotspots for increased recombination by SCE (Durkin and Glover, 2007). Given that 70% of all gaps and breaks at a common fragile site also have SCEs at these sites, our observation of ATR-dependent increase in MTSs paralleled by ATR-dependent increase in T-SCE underscores the notion that telomeres are bona fide fragile sites whose stability is protected by ATR (Glover and Stein, 1987). Telomeres present inherent difficulties for the replication machinery, including topological interference by the t-loop and the tendency for secondary structure formation (such as G-quadruplexes) within repetitive sequences (Gilson and Géli, 2007). Replication forks stall naturally at mammalian telomeres and require an ATR-dependent restart for replication to complete (Verdun and Karlseder, 2006) and depend on TRF1 for efficiency of completion (Sfeir et al., 2009). Similarly, the fission yeast homologue of TRF1, Taz1, is crucial for efficient replication of yeast telomeres (Miller et al., 2006). Thus, similarly to the case for TRF1, increased telomere fragility in the absence of ATR most likely results from replication fork stalling at telomeres. Interestingly, budding yeast Mec1 has been proposed to have roles facilitating fork progression at specific regions in the genome (Cha and Kleckner, 2002), which are characterized by slow replication, as well as in regulating dNTP pools (Zhao et al., 1998), suggesting essential roles for Mec1 in replication.

We know from a study in yeast that ATM and ATR homologues have crucial roles in telomerase recruitment and telomere length maintenance (Moser et al., 2009), but the same does not appear to be true for higher eukaryotes, suggesting a degree of evolutionary divergence and that other mechanisms exist to enable telomerase recruitment to critically short telomeres in mice. Compared with yeast telomeres (300 bp), human (8–15 kb) and murine (30–50 kb) telomeres are extremely long, which may account for the divergence in function of the checkpoint proteins in telomere length regulation, even though other elements of telomere biology are evolutionarily conserved. Factors regulating the recruitment and action of telomerase may vary according to species and cell type or context and multiple factors may be required. For example, recent work by Zhao et al. (2009) suggests that in the case of some immortalized human cell lines under telomere equilibrium conditions, telomerase acts to lengthen most telomeres each cell cycle, whereas in yeasts, primary murine cells, and other human cell lines, telomerase has been shown by numerous groups to act preferentially on the shortest telomeres under conditions of telomere shortening similar to those used in the current study (Hemann et al., 2001; Perrem et al., 2001; Samper et al., 2001a; Liu et al., 2002; Teixeira et al., 2004; Zhao et al., 2009). Whether these very different findings reflect experimental artifacts caused by the usage of immortalized versus nonimmortalized cell lines, differences between higher eukaryote species, or differential regulation of telomerase under conditions of telomere disequilibrium remains undetermined, and careful future work is required to resolve this important discrepancy. Although we and others have shown that neither ATM or ATR alone are required for telomerase-mediated elongation of short telomeres (Feldser et al., 2006; Sabourin and Zakian, 2008; this study), it is possible that because of their functional redundancy, both kinases together might function in this capacity in mice, as recently reported for fission yeast (Moser et al., 2009). However, because of their combined essential functions in cell cycle checkpoints, codepletion of ATM and ATR results in severe embryonic lethality when ATRS/S mice are crossed with ATM−/− to generate doubly depleted offspring (Murga et al., 2009). The combined deficiency is severe enough to prevent even the generation of viable MEFs (Murga et al., 2009), meaning that this hypothesis cannot be properly tested with the currently available mouse models. ATM and ATR are both members of the PIKK family. Intriguingly, a third PIKK family member, DNA-dependent protein kinase (DNA-PK) catalytic subunit (DNA-PKcs), also has important functions at the telomere. DNA-PKcs (along with its heterodimeric regulatory subunit Ku) functions primarily in DNA double-strand break repair by nonhomologous end joining but is also required for effective telomere capping (Bailey et al., 1999; Gilley et al., 2001; Goytisolo et al., 2001). The localization of DNA-PK at telomeres and the observation of progressive telomere shortening with increasing generations of DNA-PKcs deficiency raise the intriguing mechanistic possibility that DNA-PKcs may function in telomerase recruitment in mammalian cells (Espejel et al., 2004). Further studies are required to determine whether this dramatic shortening results from degradation of telomeres related to uncapping or the fascinating possibility of a telomerase recruitment defect.

In murine cells, ATM functions to protect short telomeres (Qi et al., 2003; Wong et al., 2003). In late generation ATM−/−/Terc−/− mice, ATM loss results in a synergistic increase in telomere dysfunction and chromosome fusion. Similarly, in double mutant ATRS/S/G3 Terc−/−* cells, we also observe dramatic genomic instability and increased chromosome end-to-end fusions compared with either mutant alone, suggesting that, like ATM, ATR also functions to protect the stability of telomeres in murine cells. We hypothesize that the synergistic increase in fusions in ATRS/S/G3 Terc−/−* cells likely results from a combination of fusion of short telomeres as a protective strategy with an increased availability of chromosome ends at breaks at fragile sites, including replicating telomeres, caused by ATR deficiency.

A role for ATM and ATR in telomere length maintenance was recently studied in Arabidopsis thaliana (Vespa et al., 2005). In contrast to mammalian cells lacking ATR, A. thaliana lacking either ATM or ATR are viable, and the authors demonstrated that ATM- and ATR-null cells showed wild-type telomere length homeostasis for several generations, which is consistent with our findings in Seckel mice and previous data from ATM-null mice (Feldser et al., 2006). Collectively, these results further demonstrate that ATM and ATR have distinct functions in the DDR and telomerase regulation in higher and lower eukaryotes. In both mice and A. thaliana, cells doubly null for ATM and telomerase exhibit increased telomere dysfunction without gross telomere shortening (Qi et al., 2003; Vespa et al., 2005), but A. thaliana ATR/telomerase double mutants show profound genomic instability in concert with dramatic telomere loss. This differs to our observations of moderate telomere lengthening in ATR-deficient ATRS/S/G3 Terc−/−* MEFs and implies that in plants, ATR functions to protect telomeres from deletion or degradation but that in mammalian cells, the shelterin complex is sufficient to protect mammalian telomeres from drastic shortening in the absence of ATR and Terc.

Use of the Seckel mouse model has allowed us to monitor the effects of ATR depletion on telomere length maintenance. It is important to emphasize that ATR expression in MEFs is undetectable by Western blotting and causes cell cycle arrest defects and extreme genomic instability (Murga et al., 2009). In particular, Seckel MEFs show rapid reduction in cell proliferation and the onset of senescence by the second passage after isolation (Murga et al., 2009). Because differences in apoptosis, senescence, and proliferation rates may affect telomere length measurements, we were careful to always use only cells in the first passage after harvest. Moreover, by restricting our analysis to metaphase cells derived by mitotic arrest of actively dividing MEF cultures, we exclude apoptotic and senescent cells from analysis.

In conclusion, we show in this study that severe reduction in ATR levels does not impair telomerase recruitment to short telomeres but increases telomere fragility and telomere recombination, indicating that the important DDR checkpoint kinases ATM and ATR function differently in telomere maintenance in mammals and yeast. Given the important role of ATR in preventing telomere fragility and the occurrence of chromosomes with multiple telomere signals, our results suggest that telomere dysfunction associated with ATR deficiency may in part be responsible for some of the pathologies associated with Seckel syndrome.

Materials and methods

Generation, genotyping, and handling of mice

To generate ATRS/S/Terc−/− mice, ATRS/S mice (Murga et al., 2009) were crossed with Terc−/− animals (Blasco et al., 1997), and resulting double heterozygous breeding pairs were used to generate G1 of single Terc−/− and double ATR+/S/Terc−/− animals. G2 mouse colonies were generated by intercrossing G1 ATRS/+/Terc−/− pairs. To generate ATR+/+/G3 Terc+/−*, ATR+/+/G3 Terc−/−*, ATRS/S/G3 Terc+/−*, and ATRS/S/G3 Terc−/−* mice, we crossed ATR+/S/G2 Terc−/− males with ATR+/S/Terc+/− females. All mice analyzed were from a mixed 129Sv/C57BL6 background. Terc and Seckel mice were genotyped as described previously (Blasco et al., 1997; Murga et al., 2009). Mice were maintained at the Spanish National Cancer Centre (CNIO) under specific pathogen-free conditions in accordance with the recommendations of the Federation of European Laboratory Animal Science Associations. CT analysis of 10-wk-old mice was performed in the Molecular Imaging Unit at the CNIO using a CT scanner (VISTA; GE Healthcare). Bone density was determined for both proximal and distal femurs and expressed as Hounsfield units.

Isolation of MEFs

MEFs were isolated from day 13.5 embryos as described previously (Blasco et al., 1997), maintained in DME supplemented with 10% (vol/vol) fetal bovine serum and antibiotics/antimycotics, and grown in a 5% CO2 humidified incubator at 37°C. All MEF experiments used cells from the first passage after isolation.

Human Seckel cell lines

ATR wild-type and ATR Seckel human cell lines were obtained from the Coriell Cell Repositories.

Western blotting

Whole cell extracts were prepared from primary MEFs, and Western blots were performed as described previously (Martínez et al., 2009a). After transfer, membranes were incubated with an anti-ATR antibody (1:500; AbD Serotec) and anti–β-actin monoclonal (1:10,000; Sigma-Aldrich). Antibody binding was detected using enhanced chemiluminescence after incubation with horseradish peroxidase–coupled secondary antibody.

Telomerase repeat amplification protocol (TRAP)

TRAP was performed as described previously (Siegl-Cachedenier et al., 2007). In brief, primary MEFs were trypsinized and washed in PBS, and S-100 extracts were prepared in lysis buffer with 10% CHAPS. Protein concentration was determined by the Bio-Rad Laboratories protein assay, and two protein concentrations were used for each sample (5 and 1 µg). Extension and amplification by PCR reactions and electrophoresis were performed as described previously (Blasco et al., 1997). A negative control was included by preincubating each MEF extract with RNase for 10 min at 30°C before the extension reaction. An internal control for PCR efficiency was included.

Telomere length analysis by Q-FISH

Q-FISH was performed on metaphases harvested by incubating MEFs or ATR-deficient human cells with 0.1 µg/ml colcemid (Invitrogen) for 4 h at 37°C followed by fixation in methanol/acetic acid (3:1). Q-FISH on chromosome metaphase spreads was performed as described previously (Herrera et al., 1999; Samper et al., 2000); metaphase spreads were stained with Vectashield mounting medium for fluorescence with DAPI (Vector Laboratories). Telomere fluorescence values were extrapolated from the telomere fluorescence of lymphoma cell lines LY-R (R cells) and LY-S (S cells) with known telomere lengths of 79.9 kb and 9.7 kb, respectively. Images were recorded at room temperature using a camera (CCK; Cohu, Inc.) on a fluorescence microscope (DMRB; Leica) with a mercury vapor lamp source (CS 100 W-2; Philips) with a 100× oil objective to get a 1,000 magnification. They were captured using Q-FISH software (Leica) in linear acquisition mode. TFL-Telo software (a gift from P. Lansdorp, BC Cancer Agency, Vancouver, British Columbia, Canada) was used to quantify fluorescence intensity of telomeres (Zijlmans et al., 1997). Images from littermate ATR+/+/G3 Terc+/−*, ATR+/+/G3 Terc−/−*, ATRS/S/G3 Terc+/−*, and ATRS/S/G3 Terc−/−* metaphases as well as from human ATR wild-type and ATR Seckel cells were captured on the same day, in parallel, and blindly.

Combined Q-FISH and SKY

After Q-FISH image capture, coverslips were removed, and slides were washed in PBS for 10 min. Painting probes for each mouse chromosome were generated, labeled, hybridized, and washed according to the manufacturer's protocol (Applied Spectral Imaging) as described previously (García-Cao et al., 2004). The same metaphases previously captured for Q-FISH were relocated, and SKY images captured and processed according to Samper et al. (2001b). Images were recorded at room temperature with a Spectra Cube (SD300; Applied Spectral Imaging) mounted on an imaging microscope (Axioplan 2; Carl Zeiss, Inc.) with a 100× oil Iris objective to get a 1,000 magnification. They were captured using the SkyView 1.6 software (Applied Spectral Imaging) and processed with the Case Data Manager 5.5 software (Applied Spectral Imaging). Y chromosomes were identified by reverse DAPI banding in the original Q-FISH images.

Cytogenetic analyses

At least 56 metaphases per genotype were analyzed for chromosomal aberrations by superimposing the Q-FISH telomere image on the DAPI image using TFL-Telo. Analysis was performed blindly. Metaphases were scored for RLFs (p:p arm fusions), dicentrics (q:q arm fusions), p:q arm fusions, rings (chromosomes with two fused chromatids without telomere signal at the fusion point), chromatid fusions (fusions between chromosomes by one chromatid), complex aberrations, chromatid breaks (gaps in chromatids with an identifiable corresponding chromosome), and fragments (with two telomere signals or less without an identifiable corresponding chromosome). For MTS analysis, primary MEFs and human ATR wild-type and ATR Seckel cells were treated with aphidicolin at 0.5 µM for 24 h when indicated, as described previously (Martínez et al., 2009b).


MEFs were grown at 37°C in DME containing 10 µM 5′-bromo-2′-deoxyuridine (Sigma-Aldrich) and allowed to replicate their DNA once. 1 µg/ml colcemid was added for the last 4 h. Cells were recovered, and metaphases were prepared as described previously (Samper et al., 2000). CO-FISH was performed as described previously (Bailey et al., 2004; Gonzalo et al., 2006) using a Cy3-labeled (TTAGGG)7 probe followed by a Rhodamine green–labeled (CCCTAA)7 probe (Applied Biosystems). Images of metaphase spreads were captured at room temperature using a CCK camera on a DMRB fluorescence microscope with a mercury vapor lamp source (CS 100 W-2) with a 100× oil objective to get a 1,000 magnification. They were recorded using the Q-FISH software.

Global SCE determination

MEFs were grown at 37°C in DME containing 3 µg/µl 5′-bromo-2′-deoxyuridine for two rounds of replication. Colcemid was added at a concentration of 1 µg/ml for the last 4 h of incubation. Cells were then recovered, and metaphase chromosome spreads were prepared as described for the Q-FISH (Samper et al., 2000), and genomic SCEs were visualized using an adapted fluorescence plus Giemsa protocol as described previously (Jaco et al., 2008). Metaphases on slides were immersed in 5 µg/ml Hoechst 333258 solution (Invitrogen) and washed with abundant water. The slides were exposed to UV light for 15 min in the presence of 2× SSC and washed with water. Then, they were stained with Giemsa solution (Merck) for 2 min and washed with abundant water. Once they were dried, images were recorded using a camera (DP70; Olympus) on a research microscope (Provis AX70; Olympus) with photomicrography controller (Olympus). They were captured with immersion oil at room temperature using DP Controller and DP Manager softwares (Olympus) with a Plan-Apochromat 100× NA 1.40 oil objective to get a 1,000 magnification. Metaphases were analyzed for harlequin staining. Each color switch was scored as one SCE.

Statistical analysis and p:q ratio determination

Fisher's exact test (two sided) was used to calculate statistical significance of proportions of short telomeres in G3 littermates, T-SCE, SFEs, MTSs, chromosome fusions, fragments, breaks, and aneuploidy. The Wilcoxon-Mann-Whitney rank sum test was used for statistical comparison of median telomere length in MEFs. Statistical comparison of survival data was performed using the log rank (Mantel-Cox test). p:q telomere ratios were calculated using telomere length values from TFL-Telo for p and q arms of individual chromosomes. Ratios were calculated by dividing q/p, and proportions of chromosomes with p:q ratios greater than fivefold (q/p ≥ 5 or ≤ 0.2) were calculated. Chromosome arms with SFEs were deemed to have p:q ratios ≥5 (Morrish and Greider, 2009). A two-sided Student's t test was used to calculate the statistical significance of p:q ratios and SCE. Unless otherwise indicated in the figure legend, all data with error bars represent mean ± SEM.

Online supplemental material

Fig. S1 shows that cells derived from human Seckel patients show increased telomere fragility. Fig. S2 shows that telomerase deficiency does not worsen cranial phenotypes of Seckel mice. Online supplemental material is available at


We thank R. Serrano, E. Santos, O. Aparicio, M.E. Collado, and S. Leceta for mouse care and genotyping, S. Rodriguez and J.C. Cigudosa for performing SKY analysis, and J. Flores for pathology analyses.

C.J. McNees is a recipient of a C.J. Martin Postdoctoral Training Fellowship from the National Health and Medical Research Council of Australia. M. Murga is supported by a Ramón y Cajal contract from the Spanish Ministry of Science and Education and a grant from Fondo de Investigaciones Sanitarias. Research in the M.A. Blasco laboratory is funded by the Spanish Ministry of Innovation and Science, the Consolider-Ingenio 2010 Program, the Regional Government of Madrid, the European Union, and the Spanish Association Against Cancer. Work in O. Fernandez-Capetillo's laboratory is supported by grants from the Spanish Ministry of Science, Epigenome Network of Excellence, and European Research Council.


Abbreviations used in this paper:

alternative lengthening of telomeres
ataxia telangiectasia mutated
ATM and Rad3 related
chromosome orientation FISH
computed tomography
DNA damage response
DNA-dependent protein kinase
DNA-PK catalytic subunit
mouse embryonic fibroblast
multiple telomeric signal
phosphoinositide-3-kinase–related kinase
quantitative FISH
Robertsonian-like fusion
sister chromatid exchange
signal-free end
spectral karyotyping
telomerase repeat amplification protocol
telomere SCE


  • Bailey S.M., Meyne J., Chen D.J., Kurimasa A., Li G.C., Lehnert B.E., Goodwin E.H. 1999. DNA double-strand break repair proteins are required to cap the ends of mammalian chromosomes. Proc. Natl. Acad. Sci. USA. 96:14899–14904 10.1073/pnas.96.26.14899 [PubMed] [Cross Ref]
  • Bailey S.M., Brenneman M.A., Goodwin E.H. 2004. Frequent recombination in telomeric DNA may extend the proliferative life of telomerase-negative cells. Nucleic Acids Res. 32:3743–3751 10.1093/nar/gkh691 [PMC free article] [PubMed] [Cross Ref]
  • Benetti R., García-Cao M., Blasco M.A. 2007a. Telomere length regulates the epigenetic status of mammalian telomeres and subtelomeres. Nat. Genet. 39:243–250 10.1038/ng1952 [PubMed] [Cross Ref]
  • Benetti R., Gonzalo S., Jaco I., Schotta G., Klatt P., Jenuwein T., Blasco M.A. 2007b. Suv4-20h deficiency results in telomere elongation and derepression of telomere recombination. J. Cell Biol. 178:925–936 10.1083/jcb.200703081 [PMC free article] [PubMed] [Cross Ref]
  • Bi X., Srikanta D., Fanti L., Pimpinelli S., Badugu R., Kellum R., Rong Y.S. 2005. Drosophila ATM and ATR checkpoint kinases control partially redundant pathways for telomere maintenance. Proc. Natl. Acad. Sci. USA. 102:15167–15172 10.1073/pnas.0504981102 [PubMed] [Cross Ref]
  • Bianchi A., Negrini S., Shore D. 2004. Delivery of yeast telomerase to a DNA break depends on the recruitment functions of Cdc13 and Est1. Mol. Cell. 16:139–146 10.1016/j.molcel.2004.09.009 [PubMed] [Cross Ref]
  • Blasco M.A. 2005. Telomeres and human disease: ageing, cancer and beyond. Nat. Rev. Genet. 6:611–622 10.1038/nrg1656 [PubMed] [Cross Ref]
  • Blasco M.A., Lee H.W., Hande M.P., Samper E., Lansdorp P.M., DePinho R.A., Greider C.W. 1997. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell. 91:25–34 10.1016/S0092-8674(01)80006-4 [PubMed] [Cross Ref]
  • Brown E.J., Baltimore D. 2000. ATR disruption leads to chromosomal fragmentation and early embryonic lethality. Genes Dev. 14:397–402 [PubMed]
  • Brown E.J., Baltimore D. 2003. Essential and dispensable roles of ATR in cell cycle arrest and genome maintenance. Genes Dev. 17:615–628 10.1101/gad.1067403 [PubMed] [Cross Ref]
  • Casper A.M., Nghiem P., Arlt M.F., Glover T.W. 2002. ATR regulates fragile site stability. Cell. 111:779–789 10.1016/S0092-8674(02)01113-3 [PubMed] [Cross Ref]
  • Casper A.M., Durkin S.G., Arlt M.F., Glover T.W. 2004. Chromosomal instability at common fragile sites in Seckel syndrome. Am. J. Hum. Genet. 75:654–660 10.1086/422701 [PubMed] [Cross Ref]
  • Cha R.S., Kleckner N. 2002. ATR homolog Mec1 promotes fork progression, thus averting breaks in replication slow zones. Science. 297:602–606 10.1126/science.1071398 [PubMed] [Cross Ref]
  • Chan S.W., Blackburn E.H. 2002. New ways not to make ends meet: telomerase, DNA damage proteins and heterochromatin. Oncogene. 21:553–563 10.1038/sj.onc.1205082 [PubMed] [Cross Ref]
  • Chan S.W., Chang J., Prescott J., Blackburn E.H. 2001. Altering telomere structure allows telomerase to act in yeast lacking ATM kinases. Curr. Biol. 11:1240–1250 10.1016/S0960-9822(01)00391-8 [PubMed] [Cross Ref]
  • d'Adda di Fagagna F., Reaper P.M., Clay-Farrace L., Fiegler H., Carr P., Von Zglinicki T., Saretzki G., Carter N.P., Jackson S.P. 2003. A DNA damage checkpoint response in telomere-initiated senescence. Nature. 426:194–198 10.1038/nature02118 [PubMed] [Cross Ref]
  • Dahlen M., Olsson T., Kanter-Smoler G., Ramne A., Sunnerhagen P. 1998. Regulation of telomere length by checkpoint genes in Schizosaccharomyces pombe. Mol. Biol. Cell. 9:611–621 [PMC free article] [PubMed]
  • de Klein A., Muijtjens M., van Os R., Verhoeven Y., Smit B., Carr A.M., Lehmann A.R., Hoeijmakers J.H. 2000. Targeted disruption of the cell-cycle checkpoint gene ATR leads to early embryonic lethality in mice. Curr. Biol. 10:479–482 10.1016/S0960-9822(00)00447-4 [PubMed] [Cross Ref]
  • DuBois M.L., Haimberger Z.W., McIntosh M.W., Gottschling D.E. 2002. A quantitative assay for telomere protection in Saccharomyces cerevisiae. Genetics. 161:995–1013 [PubMed]
  • Durkin S.G., Glover T.W. 2007. Chromosome fragile sites. Annu. Rev. Genet. 41:169–192 10.1146/annurev.genet.41.042007.165900 [PubMed] [Cross Ref]
  • Espejel S., Martín M., Klatt P., Martín-Caballero J., Flores J.M., Blasco M.A. 2004. Shorter telomeres, accelerated ageing and increased lymphoma in DNA-PKcs-deficient mice. EMBO Rep. 5:503–509 10.1038/sj.embor.7400127 [PubMed] [Cross Ref]
  • Feldser D., Strong M.A., Greider C.W. 2006. Ataxia telangiectasia mutated (Atm) is not required for telomerase-mediated elongation of short telomeres. Proc. Natl. Acad. Sci. USA. 103:2249–2251 10.1073/pnas.0511143103 [PubMed] [Cross Ref]
  • Flores I., Cayuela M.L., Blasco M.A. 2005. Effects of telomerase and telomere length on epidermal stem cell behavior. Science. 309:1253–1256 10.1126/science.1115025 [PubMed] [Cross Ref]
  • García-Cao M., O'Sullivan R., Peters A.H., Jenuwein T., Blasco M.A. 2004. Epigenetic regulation of telomere length in mammalian cells by the Suv39h1 and Suv39h2 histone methyltransferases. Nat. Genet. 36:94–99 10.1038/ng1278 [PubMed] [Cross Ref]
  • Gilley D., Tanaka H., Hande M.P., Kurimasa A., Li G.C., Oshimura M., Chen D.J. 2001. DNA-PKcs is critical for telomere capping. Proc. Natl. Acad. Sci. USA. 98:15084–15088 10.1073/pnas.261574698 [PubMed] [Cross Ref]
  • Gilson E., Géli V. 2007. How telomeres are replicated. Nat. Rev. Mol. Cell Biol. 8:825–838 10.1038/nrm2259 [PubMed] [Cross Ref]
  • Glover T.W., Stein C.K. 1987. Induction of sister chromatid exchanges at common fragile sites. Am. J. Hum. Genet. 41:882–890 [PubMed]
  • Glover T.W., Stein C.K. 1988. Chromosome breakage and recombination at fragile sites. Am. J. Hum. Genet. 43:265–273 [PubMed]
  • Gonzalo S., Jaco I., Fraga M.F., Chen T., Li E., Esteller M., Blasco M.A. 2006. DNA methyltransferases control telomere length and telomere recombination in mammalian cells. Nat. Cell Biol. 8:416–424 10.1038/ncb1386 [PubMed] [Cross Ref]
  • Goytisolo F.A., Samper E., Edmonson S., Taccioli G.E., Blasco M.A. 2001. The absence of the dna-dependent protein kinase catalytic subunit in mice results in anaphase bridges and in increased telomeric fusions with normal telomere length and G-strand overhang. Mol. Cell. Biol. 21:3642–3651 10.1128/MCB.21.11.3642-3651.2001 [PMC free article] [PubMed] [Cross Ref]
  • Greenwell P.W., Kronmal S.L., Porter S.E., Gassenhuber J., Obermaier B., Petes T.D. 1995. TEL1, a gene involved in controlling telomere length in S. cerevisiae, is homologous to the human ataxia telangiectasia gene. Cell. 82:823–829 10.1016/0092-8674(95)90479-4 [PubMed] [Cross Ref]
  • Guo X., Deng Y., Lin Y., Cosme-Blanco W., Chan S., He H., Yuan G., Brown E.J., Chang S. 2007. Dysfunctional telomeres activate an ATM-ATR-dependent DNA damage response to suppress tumorigenesis. EMBO J. 26:4709–4719 10.1038/sj.emboj.7601893 [PubMed] [Cross Ref]
  • Hande M.P., Samper E., Lansdorp P., Blasco M.A. 1999. Telomere length dynamics and chromosomal instability in cells derived from telomerase null mice. J. Cell Biol. 144:589–601 10.1083/jcb.144.4.589 [PMC free article] [PubMed] [Cross Ref]
  • Hande M.P., Balajee A.S., Tchirkov A., Wynshaw-Boris A., Lansdorp P.M. 2001. Extra-chromosomal telomeric DNA in cells from Atm(-/-) mice and patients with ataxia-telangiectasia. Hum. Mol. Genet. 10:519–528 10.1093/hmg/10.5.519 [PubMed] [Cross Ref]
  • Hemann M.T., Strong M.A., Hao L.Y., Greider C.W. 2001. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell. 107:67–77 10.1016/S0092-8674(01)00504-9 [PubMed] [Cross Ref]
  • Herrera E., Samper E., Martín-Caballero J., Flores J.M., Lee H.W., Blasco M.A. 1999. Disease states associated with telomerase deficiency appear earlier in mice with short telomeres. EMBO J. 18:2950–2960 10.1093/emboj/18.11.2950 [PubMed] [Cross Ref]
  • Hofer A.C., Tran R.T., Aziz O.Z., Wright W., Novelli G., Shay J., Lewis M. 2005. Shared phenotypes among segmental progeroid syndromes suggest underlying pathways of aging. J. Gerontol. A Biol. Sci. Med. Sci. 60:10–20 [PubMed]
  • Jaco I., Canela A., Vera E., Blasco M.A. 2008. Centromere mitotic recombination in mammalian cells. J. Cell Biol. 181:885–892 10.1083/jcb.200803042 [PMC free article] [PubMed] [Cross Ref]
  • Lendvay T.S., Morris D.K., Sah J., Balasubramanian B., Lundblad V. 1996. Senescence mutants of Saccharomyces cerevisiae with a defect in telomere replication identify three additional EST genes. Genetics. 144:1399–1412 [PubMed]
  • Lin J.J., Dutta A. 2007. ATR pathway is the primary pathway for activating G2/M checkpoint induction after re-replication. J. Biol. Chem. 282:30357–30362 10.1074/jbc.M705178200 [PubMed] [Cross Ref]
  • Liu Y., Kha H., Ungrin M., Robinson M.O., Harrington L. 2002. Preferential maintenance of critically short telomeres in mammalian cells heterozygous for mTert. Proc. Natl. Acad. Sci. USA. 99:3597–3602 10.1073/pnas.062549199 [PubMed] [Cross Ref]
  • Longhese M.P. 2008. DNA damage response at functional and dysfunctional telomeres. Genes Dev. 22:125–140 10.1101/gad.1626908 [PubMed] [Cross Ref]
  • Lustig A.J., Petes T.D. 1986. Identification of yeast mutants with altered telomere structure. Proc. Natl. Acad. Sci. USA. 83:1398–1402 10.1073/pnas.83.5.1398 [PubMed] [Cross Ref]
  • Martens U.M., Zijlmans J.M., Poon S.S., Dragowska W., Yui J., Chavez E.A., Ward R.K., Lansdorp P.M. 1998. Short telomeres on human chromosome 17p. Nat. Genet. 18:76–80 [PubMed]
  • Martínez P., Siegl-Cachedenier I., Flores J.M., Blasco M.A. 2009a. MSH2 deficiency abolishes the anticancer and pro-aging activity of short telomeres. Aging Cell. 8:2–17 10.1111/j.1474-9726.2008.00441.x [PubMed] [Cross Ref]
  • Martínez P., Thanasoula M., Muñoz P., Liao C., Tejera A., McNees C., Flores J.M., Fernández-Capetillo O., Tarsounas M., Blasco M.A. 2009b. Increased telomere fragility and fusions resulting from TRF1 deficiency lead to degenerative pathologies and increased cancer in mice. Genes Dev. 23:2060–2075 10.1101/gad.543509 [PubMed] [Cross Ref]
  • Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R., III, Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., et al. 2007. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science. 316:1160–1166 10.1126/science.1140321 [PubMed] [Cross Ref]
  • Metcalfe J.A., Parkhill J., Campbell L., Stacey M., Biggs P., Byrd P.J., Taylor A.M. 1996. Accelerated telomere shortening in ataxia telangiectasia. Nat. Genet. 13:350–353 10.1038/ng0796-350 [PubMed] [Cross Ref]
  • Miller K.M., Rog O., Cooper J.P. 2006. Semi-conservative DNA replication through telomeres requires Taz1. Nature. 440:824–828 10.1038/nature04638 [PubMed] [Cross Ref]
  • Morrish T.A., Greider C.W. 2009. Short telomeres initiate telomere recombination in primary and tumor cells. PLoS Genet. 5:e1000357 10.1371/journal.pgen.1000357 [PMC free article] [PubMed] [Cross Ref]
  • Moser B.A., Subramanian L., Khair L., Chang Y.T., Nakamura T.M. 2009. Fission yeast Tel1(ATM) and Rad3(ATR) promote telomere protection and telomerase recruitment. PLoS Genet. 5:e1000622 10.1371/journal.pgen.1000622 [PMC free article] [PubMed] [Cross Ref]
  • Murga M., Bunting S., Montaña M.F., Soria R., Mulero F., Cañamero M., Lee Y., McKinnon P.J., Nussenzweig A., Fernandez-Capetillo O. 2009. A mouse model of ATR-Seckel shows embryonic replicative stress and accelerated aging. Nat. Genet. 41:891–898 10.1038/ng.420 [PMC free article] [PubMed] [Cross Ref]
  • Nakamura T.M., Moser B.A., Russell P. 2002. Telomere binding of checkpoint sensor and DNA repair proteins contributes to maintenance of functional fission yeast telomeres. Genetics. 161:1437–1452 [PubMed]
  • O'Driscoll M., Ruiz-Perez V.L., Woods C.G., Jeggo P.A., Goodship J.A. 2003. A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome. Nat. Genet. 33:497–501 10.1038/ng1129 [PubMed] [Cross Ref]
  • Palm W., de Lange T. 2008. How shelterin protects mammalian telomeres. Annu. Rev. Genet. 42:301–334 10.1146/annurev.genet.41.110306.130350 [PubMed] [Cross Ref]
  • Pandita T.K. 2002. ATM function and telomere stability. Oncogene. 21:611–618 10.1038/sj.onc.1205060 [PubMed] [Cross Ref]
  • Pennock E., Buckley K., Lundblad V. 2001. Cdc13 delivers separate complexes to the telomere for end protection and replication. Cell. 104:387–396 10.1016/S0092-8674(01)00226-4 [PubMed] [Cross Ref]
  • Perrem K., Colgin L.M., Neumann A.A., Yeager T.R., Reddel R.R. 2001. Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells. Mol. Cell. Biol. 21:3862–3875 10.1128/MCB.21.12.3862-3875.2001 [PMC free article] [PubMed] [Cross Ref]
  • Pignolo R.J., Suda R.K., McMillan E.A., Shen J., Lee S.H., Choi Y., Wright A.C., Johnson F.B. 2008. Defects in telomere maintenance molecules impair osteoblast differentiation and promote osteoporosis. Aging Cell. 7:23–31 10.1111/j.1474-9726.2007.00350.x [PMC free article] [PubMed] [Cross Ref]
  • Poon S.S., Martens U.M., Ward R.K., Lansdorp P.M. 1999. Telomere length measurements using digital fluorescence microscopy. Cytometry. 36:267–278 10.1002/(SICI)1097-0320(19990801)36:4<267::AID-CYTO1>3.0.CO;2-O [PubMed] [Cross Ref]
  • Qi L., Strong M.A., Karim B.O., Armanios M., Huso D.L., Greider C.W. 2003. Short telomeres and ataxia-telangiectasia mutated deficiency cooperatively increase telomere dysfunction and suppress tumorigenesis. Cancer Res. 63:8188–8196 [PubMed]
  • Ritchie K.B., Mallory J.C., Petes T.D. 1999. Interactions of TLC1 (which encodes the RNA subunit of telomerase), TEL1, and MEC1 in regulating telomere length in the yeast Saccharomyces cerevisiae. Mol. Cell. Biol. 19:6065–6075 [PMC free article] [PubMed]
  • Ruzankina Y., Pinzon-Guzman C., Asare A., Ong T., Pontano L., Cotsarelis G., Zediak V.P., Velez M., Bhandoola A., Brown E.J. 2007. Deletion of the developmentally essential gene ATR in adult mice leads to age-related phenotypes and stem cell loss. Cell Stem Cell. 1:113–126 10.1016/j.stem.2007.03.002 [PMC free article] [PubMed] [Cross Ref]
  • Sabourin M., Zakian V.A. 2008. ATM-like kinases and regulation of telomerase: lessons from yeast and mammals. Trends Cell Biol. 18:337–346 10.1016/j.tcb.2008.04.004 [PMC free article] [PubMed] [Cross Ref]
  • Samper E., Goytisolo F.A., Slijepcevic P., van Buul P.P., Blasco M.A. 2000. Mammalian Ku86 protein prevents telomeric fusions independently of the length of TTAGGG repeats and the G-strand overhang. EMBO Rep. 1:244–252 10.1093/embo-reports/kvd051 [PubMed] [Cross Ref]
  • Samper E., Flores J.M., Blasco M.A. 2001a. Restoration of telomerase activity rescues chromosomal instability and premature aging in Terc-/- mice with short telomeres. EMBO Rep. 2:800–807 10.1093/embo-reports/kve174 [PubMed] [Cross Ref]
  • Samper E., Goytisolo F.A., Ménissier-de Murcia J., González-Suárez E., Cigudosa J.C., de Murcia G., Blasco M.A. 2001b. Normal telomere length and chromosomal end capping in poly(ADP-ribose) polymerase–deficient mice and primary cells despite increased chromosomal instability. J. Cell Biol. 154:49–60 10.1083/jcb.200103049 [PMC free article] [PubMed] [Cross Ref]
  • Sfeir A., Kosiyatrakul S.T., Hockemeyer D., MacRae S.L., Karlseder J., Schildkraut C.L., de Lange T. 2009. Mammalian telomeres resemble fragile sites and require TRF1 for efficient replication. Cell. 138:90–103 10.1016/j.cell.2009.06.021 [PMC free article] [PubMed] [Cross Ref]
  • Siegl-Cachedenier I., Flores I., Klatt P., Blasco M.A. 2007. Telomerase reverses epidermal hair follicle stem cell defects and loss of long-term survival associated with critically short telomeres. J. Cell Biol. 179:277–290 10.1083/jcb.200704141 [PMC free article] [PubMed] [Cross Ref]
  • Singer M.S., Gottschling D.E. 1994. TLC1: template RNA component of Saccharomyces cerevisiae telomerase. Science. 266:404–409 10.1126/science.7545955 [PubMed] [Cross Ref]
  • Sprung C.N., Bryan T.M., Reddel R.R., Murnane J.P. 1997. Normal telomere maintenance in immortal ataxia telangiectasia cell lines. Mutat. Res. 379:177–184 [PubMed]
  • Takai H., Smogorzewska A., de Lange T. 2003. DNA damage foci at dysfunctional telomeres. Curr. Biol. 13:1549–1556 10.1016/S0960-9822(03)00542-6 [PubMed] [Cross Ref]
  • Teixeira M.T., Arneric M., Sperisen P., Lingner J. 2004. Telomere length homeostasis is achieved via a switch between telomerase- extendible and -nonextendible states. Cell. 117:323–335 10.1016/S0092-8674(04)00334-4 [PubMed] [Cross Ref]
  • Tseng S.F., Lin J.J., Teng S.C. 2006. The telomerase-recruitment domain of the telomere binding protein Cdc13 is regulated by Mec1p/Tel1p-dependent phosphorylation. Nucleic Acids Res. 34:6327–6336 10.1093/nar/gkl786 [PubMed] [Cross Ref]
  • Tsukamoto Y., Taggart A.K., Zakian V.A. 2001. The role of the Mre11-Rad50-Xrs2 complex in telomerase- mediated lengthening of Saccharomyces cerevisiae telomeres. Curr. Biol. 11:1328–1335 10.1016/S0960-9822(01)00372-4 [PubMed] [Cross Ref]
  • Verdun R.E., Karlseder J. 2006. The DNA damage machinery and homologous recombination pathway act consecutively to protect human telomeres. Cell. 127:709–720 10.1016/j.cell.2006.09.034 [PubMed] [Cross Ref]
  • Vespa L., Couvillion M., Spangler E., Shippen D.E. 2005. ATM and ATR make distinct contributions to chromosome end protection and the maintenance of telomeric DNA in Arabidopsis. Genes Dev. 19:2111–2115 10.1101/gad.1333805 [PubMed] [Cross Ref]
  • Wong K.K., Maser R.S., Bachoo R.M., Menon J., Carrasco D.R., Gu Y., Alt F.W., DePinho R.A. 2003. Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing. Nature. 421:643–648 10.1038/nature01385 [PubMed] [Cross Ref]
  • Zhao X., Muller E.G., Rothstein R. 1998. A suppressor of two essential checkpoint genes identifies a novel protein that negatively affects dNTP pools. Mol. Cell. 2:329–340 10.1016/S1097-2765(00)80277-4 [PubMed] [Cross Ref]
  • Zhao Y., Sfeir A.J., Zou Y., Buseman C.M., Chow T.T., Shay J.W., Wright W.E. 2009. Telomere extension occurs at most chromosome ends and is uncoupled from fill-in in human cancer cells. Cell. 138:463–475 10.1016/j.cell.2009.05.026 [PMC free article] [PubMed] [Cross Ref]
  • Zijlmans J.M., Martens U.M., Poon S.S., Raap A.K., Tanke H.J., Ward R.K., Lansdorp P.M. 1997. Telomeres in the mouse have large inter-chromosomal variations in the number of T2AG3 repeats. Proc. Natl. Acad. Sci. USA. 94:7423–7428 10.1073/pnas.94.14.7423 [PubMed] [Cross Ref]

Articles from The Journal of Cell Biology are provided here courtesy of The Rockefeller University Press